Search research articles
Contact Us
Filters
Showing results (171-180 of 254) with videos related to
Page
of 26
Sort By:
Cardiovascular Diabetology
|
August 1, 2021
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Diabetes Research and Clinical Practice
|
October 7, 2016
Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP)
Yoshio Fujitani, Shimpei Fujimoto, Kiyohito Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 8, 2021
[Spontaneous resolution of refractory ascites in the late phase after cord blood transplantation in acute myeloid leukemia]
Toshikuni Kawamura, Masahiro Teramoto, Takehiro Sone, et al.
Endocrine Journal
|
February 6, 2020
Usefulness of the index calculated as the product of levels of fasting plasma glucose and hemoglobin A1c for insulinoma screening
Keiichi Torimoto, Yosuke Okada, Yoshiya Tanaka, et al.
Endocrine Journal
|
January 26, 2018
Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1
Akira Kurozumi, Yosuke Okada, Hiroaki Satoh, et al.
Cardiovascular Diabetology
|
January 8, 2021
Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes
Satomi Wakasugi, Tomoya Mita, Naoto Katakami, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
May 24, 2024
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
American Journal of Clinical Pathology
|
May 16, 2012
Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders
Hiroaki Miyoshi, Kensaku Sato, Daisuke Niino, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 30, 2026
Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes
Fumiya Sato, Tomoya Mita, Naoto Katakami, et al.
Cardiovascular Diabetology
|
January 9, 2020
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 254) with videos related to
Sort By:
Page
of 26
Cardiovascular Diabetology
|
August 1, 2021
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Diabetes Research and Clinical Practice
|
October 7, 2016
Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP)
Yoshio Fujitani, Shimpei Fujimoto, Kiyohito Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 8, 2021
[Spontaneous resolution of refractory ascites in the late phase after cord blood transplantation in acute myeloid leukemia]
Toshikuni Kawamura, Masahiro Teramoto, Takehiro Sone, et al.
Endocrine Journal
|
February 6, 2020
Usefulness of the index calculated as the product of levels of fasting plasma glucose and hemoglobin A1c for insulinoma screening
Keiichi Torimoto, Yosuke Okada, Yoshiya Tanaka, et al.
Endocrine Journal
|
January 26, 2018
Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1
Akira Kurozumi, Yosuke Okada, Hiroaki Satoh, et al.
Cardiovascular Diabetology
|
January 8, 2021
Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes
Satomi Wakasugi, Tomoya Mita, Naoto Katakami, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
May 24, 2024
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial
Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
American Journal of Clinical Pathology
|
May 16, 2012
Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders
Hiroaki Miyoshi, Kensaku Sato, Daisuke Niino, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 30, 2026
Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes
Fumiya Sato, Tomoya Mita, Naoto Katakami, et al.
Cardiovascular Diabetology
|
January 9, 2020
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, et al.
Page
of 26